This Article Full Text Correction (v94,p2668) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sheth, S. Articles by Eigler, N. Search for Related Content PubMed PubMed Citation Articles by Sheth, S. Articles by Eigler, N.

(Circulation. 1996;94:1733-1740.)
© 1996 American Heart Association, Inc.

Articles

Subacute Thrombosis and Vascular Injury Resulting From Slotted-Tube Nitinol and Stainless Steel Stents in a Rabbit Carotid Artery Model

Sushil Sheth, MD; Frank Litvack, MD; Vishva Dev, MD; Michael C. Fishbein, MD; James S. Forrester, MD; Neal Eigler, MD

the Division of Cardiology and the Cardiovascular Intervention Research Center, Department of Medicine and the Department of Pathology, Cedars-Sinai Medical Center, the Cedars-Sinai Research Institute and the UCLA School of Medicine, Los Angeles, Calif.

Correspondence to Neal Eigler, MD, Cardiovascular Intervention Center, Cedars-Sinai Medical Center, 8700 Beverly Blvd, #6560, Los Angeles, CA 90048.

Background Our objectives were to quantify the thrombogenicity and extent of vascular injury created by slotted-tube geometry stainless steel and nitinol coronary stents in a rabbit carotid artery model.

Methods and Results Stents were implanted in rabbit right carotid arteries without antiplatelet therapy. Stainless steel stents were implanted for 4 days while nitinol stents were placed for 4 and 14 days (n=8, 8, and 6, respectively). Stent thrombosis was assessed by thrombus weight, grading thrombus encroachment of the lumen, and by blood flow in the stented and contralateral arteries. Stainless steel stents at 4 days contained more thrombus than 4- and 14-day nitinol stents (20.0±5.9 versus 2.5±0.6 and 2.7±0.3 mg, respectively; P<.000001). Stainless steel stents were more often occluded by thrombus (6 of 8) or contained more subocclusive thrombus (2 of 8) than nitinol stents (0 of 14, P<.002). Resting blood flow was reduced in arteries with stainless steel stents compared with 4- and 14-day nitinol stents (1.5±2.8 versus 24.0±2.0 and 25.5±1.9 mL/min, respectively, P<.000001). Stainless steel stents were less uniformly expanded, had deeper strut penetration into the vascular wall, and were associated with more extensive medial smooth muscle cell necrosis. There were strong correlations (r=.77 to .95) between variables of thrombosis extent (thrombus weight and grade) and histologically determined vascular injury (strut penetration and medial necrosis).

Conclusions Slotted-tube stainless steel stents were more thrombogenic and created more extensive vascular injury than nitinol stents in a rabbit carotid artery model. The mechanisms underlying these differences probably are related to metallurgic and design geometry properties of the two stent types.

Key Words: prosthesis • angioplasty • coronary artery disease • revascularization • stents • thrombosis

This article has been cited by other articles:

				Y.-C. Weon, S.-G. Kang, J. W. Chung, Y. I. Kim, J. H. Park, and D. Y. Lee Technical feasibility and biocompatibility of a newly designed separating stent-graft in the normal canine aorta. Am. J. Roentgenol., April 1, 2006; 186(4): 1148 - 1154. [Abstract] [Full Text] [PDF]

				N. von Beckerath, W. Koch, J. Mehilli, C. Bottiger, A. Schomig, and A. Kastrati Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting Blood, June 1, 2000; 95(11): 3297 - 3301. [Abstract] [Full Text] [PDF]

				A. Kastrati, A. Schomig, J. Dirschinger, J. Mehilli, N. von Welser, J. Pache, H. Schuhlen, T. Schilling, C. Schmitt, and F.-J. Neumann Increased Risk of Restenosis After Placement of Gold-Coated Stents : Results of a Randomized Trial Comparing Gold-Coated With Uncoated Steel Stents in Patients With Coronary Artery Disease Circulation, May 30, 2000; 101(21): 2478 - 2483. [Abstract] [Full Text] [PDF]

				C. Stefanadis, K. Toutouzas, E. Tsiamis, C. Vlachopoulos, S. Vaina, D. Tsekoura, L. Haldi, E. Stefanadi, M. Gravanis, and P. Toutouzas Stents covered by an autologous arterial graft in porcine coronary arteries: feasibility, vascular injury and effect on neointimal hyperplasia Cardiovasc Res, February 1, 1999; 41(2): 433 - 442. [Abstract] [Full Text] [PDF]

				E. J. Topol and P. W. Serruys Frontiers in Interventional Cardiology Circulation, October 27, 1998; 98(17): 1802 - 1820. [Full Text] [PDF]

				O. F. Bertrand, R. Sipehia, R. Mongrain, J. Rodes, J.-C. Tardif, L. Bilodeau, G. Cote, and M. G. Bourassa Biocompatibility aspects of new stent technology J. Am. Coll. Cardiol., September 1, 1998; 32(3): 562 - 571. [Abstract] [Full Text] [PDF]

				R. R. Makkar, F. Litvack, N. L. Eigler, M. Nakamura, P. A. Ivey, J. S. Forrester, P. K. Shah, R. E. Jordan, and S. Kaul Effects of GP IIb/IIIa Receptor Monoclonal Antibody (7E3), Heparin, and Aspirin in an Ex Vivo Canine Arteriovenous Shunt Model of Stent Thrombosis Circulation, February 18, 1997; 95(4): 1015 - 1021. [Abstract] [Full Text]